The stock price of Cue Health Inc. (NASDAQ: HLTH) has jumped by 11.65 compared to previous close of 0.58. Despite this, the company has seen a gain of 22.86% in its stock price over the last five trading days. Seeking Alpha reported 2023-08-09 that Cue Health Inc. (NASDAQ:HLTH ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Lorna Williams – IR Ayub Khattak – Co-Founder, President, CEO & Chairman Aasim Javed – CFO Conference Call Participants David Delahunt – Goldman Sachs Charles Rhyee – TD Cowen Operator Good day and thank you for standing by. Welcome to the Cue Health Second Quarter 2023 Earnings Conference Call.
Is It Worth Investing in Cue Health Inc. (NASDAQ: HLTH) Right Now?
, and the 36-month beta value for HLTH is at 0.97. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The average price suggested by analysts for HLTH is $3.58, which is $3.3 above the current market price. The public float for HLTH is 135.31M, and currently, shorts hold a 0.98% of that float. The average trading volume for HLTH on September 18, 2023 was 866.58K shares.
HLTH’s Market Performance
HLTH stock saw an increase of 22.86% in the past week, with a monthly gain of 87.50% and a quarterly increase of 29.47%. The volatility ratio for the week is 21.80%, and the volatility levels for the last 30 days are 16.65% for Cue Health Inc. (HLTH). The simple moving average for the past 20 days is 32.35% for HLTH’s stock, with a -53.35% simple moving average for the past 200 days.
HLTH Trading at 43.28% from the 50-Day Moving Average
After a stumble in the market that brought HLTH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.27% of loss for the given period.
Volatility was left at 16.65%, however, over the last 30 days, the volatility rate increased by 21.80%, as shares surge +86.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +84.18% upper at present.
During the last 5 trading sessions, HLTH rose by +22.86%, which changed the moving average for the period of 200-days by -75.48% in comparison to the 20-day moving average, which settled at $0.5023. In addition, Cue Health Inc. saw -68.84% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at HLTH starting from Sever Clint, who sale 29,269 shares at the price of $3.02 back on Dec 08. After this action, Sever Clint now owns 3,939,647 shares of Cue Health Inc., valued at $88,334 using the latest closing price.
Sever Clint, the Chief Product Officer of Cue Health Inc., sale 24,147 shares at $2.98 during a trade that took place back on Dec 07, which means that Sever Clint is holding 3,939,647 shares at $71,958 based on the most recent closing price.
Stock Fundamentals for HLTH
Current profitability levels for the company are sitting at:
- -42.12 for the present operating margin
- +31.75 for the gross margin
The net margin for Cue Health Inc. stands at -40.14. The total capital return value is set at -29.14, while invested capital returns managed to touch -28.17. Equity return is now at value -52.90, with -41.60 for asset returns.
Based on Cue Health Inc. (HLTH), the company’s capital structure generated 9.54 points at debt to equity in total, while total debt to capital is 8.71. Total debt to assets is 7.92, with long-term debt to equity ratio resting at 7.79. Finally, the long-term debt to capital ratio is 7.11.
When we switch over and look at the enterprise to sales, we see a ratio of -0.35, with the company’s debt to enterprise value settled at 0.46. The receivables turnover for the company is 7.75 and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.21.
In conclusion, Cue Health Inc. (HLTH) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.